Senior Director, Cancer Genomics
This job is no longer available
There are still lots of open positions. Let's find the one that's right for you.
About The Position
Revolution Medicines is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit frontier targets in RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) Inhibitors designed to suppress diverse oncogenic variants of RAS proteins, and RAS Companion Inhibitors for use in combination treatment strategies. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Translational Medicine (TM) team at RevMed is seeking a highly motivated, scientifically creative, and collaborative Senior Director of Cancer Genomics to work in a fast-paced environment within a cross-functional team. This role will be leading a group of translational scientists to identify novel genomic assays that can gain insights into predictive/prognostic biomarkers and accelerate clinical development programs. The position will serve as a subject-matter expert (SME) for cancer genomics in RAS-driven solid tumor types and emerging genomic assays.
